HIGHLIGHTS
- who: Nasopharyngeal carcinoma - ifosfamide and colleagues from the (UNIVERSITY) have published the Article: RESEARCH COMMUNICATION Patients, in the Journal: (JOURNAL)
- what: The aim of this study is investigating the efficacy of ifosfamide and doxorubicin combination as second line treatment in patients with recurrent and metastatic NPC.
SUMMARY
This ratio is reported as high as 38-87 % in autopsy series (Perez et_al, 1992; Fong et_al, 1996; Brady et_al, 2010). To date, no randomized controlled trial, comparing different CT regimens in metastatic NPC is reported. But there is no single regimen accepted generally . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.